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Introduction
Well-known examples of heat-induced damage include denaturation of proteins ͓1-3͔, increased cell necrosis ͓4͔ and membrane permeability ͓5͔, and irreversible changes in the mechanical properties of soft tissue ͓6,7͔. Chen and Humphrey ͓8͔ report, for example, that chordae tendineae exhibit increased compliance, extensibility, and hysteresis following heat-induced damage. Chen et al. ͓9͔ further report the free shrinkage of bovine chordae tendineae ͑primarily type 1 collagen͒ subjected to isothermal heating. The evolution of damage over the range of temperature levels T from 65 to 85°C for durations of 1 to 1200 seconds could be described by a single sigmoidal curve once the elapsed heating time at each T was scaled by a characteristic time, which in turn was related to T by an Arrhenius-type relation. Similar sigmoidal trends have been observed for other types of heat-induced damage ͓10-12͔.
Thermal diffusivity determines, in part, the temperature history of tissue and thus, the degree of heat-induced damage. Little is known, however, of possible changes in the thermal properties of tissue due to heat-induced damage. Valvano and Chitsabesan ͓13͔ measured the thermal conductivity and diffusivity of human aortic tissue at T of 35, 55, 75, and 90°C using self-heated thermistors. Although varying the order of T for the different specimens provided some insights into the possible effects of heat-induced damage on thermal diffusivity, the total exposure time of the tissue at any temperature level is not noted and therefore, the extent of heat-induced damage, as opposed to variations in thermal properties due to T, is unknown. Thus, measurement of a single component of thermal diffusivity in tissue that has undergone a welldefined damage protocol may aid in distinguishing possible changes due to heat-induced damage.
The flash method was originally developed by Parker et al. ͓14͔ as a conceptually simple way to measure thermal diffusivity in planar specimens. Briefly, the flash method uses a pulse of light, usually from a flash lamp or a laser, to heat one face of a plane sample. If the light is absorbed by the front face of the specimen, the out-of-plane component of thermal diffusivity ␣ 3 may be calculated from the solution of the diffusion equation by ␣ 3 ϭ 1.38␦ 2 2 t 1/2
(1)
where ␦ is the thickness of the specimen and t 1/2 is the time it takes for the temperature at the rear face T s to reach one-half its maximum value T max . Recently, the flash method has been adapted for measuring ␣ 3 of bovine aorta subject to biaxial deformation ͓15͔. Reported here are measurements of ␣ 3 of bovine aorta before and after heating in a mechanically unconstrained state. The heating protocol was based on insight from Chen et al. ͓9͔ and pilot measurements.
Methods and Materials
The thermomechanical test apparatus has been described in detail elsewhere ͓15͔. The essential features for these measurements are a load frame, which here serves as a specimen holder, and a flash thermal diffusivity measurement system. Briefly, a specimen with approximate dimensions of 35ϫ35ϫ2.3 mm is sutured with 3-0 silk suture to four load carriages. The carriages are moved such that the specimen is centered under a xenon flash bulb and held with just enough tension to maintain the specimen approximately planar. The in-plane directions correspond to the axial and circumferential directions of the aorta. With the bulb positioned over the top face of the specimen, one to three E-type thermocouples are brought into contact with the bottom surface. Flash thermal diffusivity measurement works best with opaque materials, with the flash energy absorbed at the surface. Thus, the illuminated ͑top͒ surface of the specimen is coated with graphite, thereby enhancing absorption of the flash energy and reducing scatter and uncertainty in the values of ␣ 3 .
Bovine aortas were obtained from a local slaughterhouse within one half-hour post-mortem and placed immediately in a physiologic solution ͑136.9 mM NaCl, 2.7 mM KCl, 1.05 mM MgCl 2 , 11.9 mM NaHCO 3 , 0.47 mM NaH 2 PO 4 , 5.5 mM Dextrose͒ containing 2.0 mM EGTA, a calcium chelator that relaxes smooth muscle cells ͓16͔. Specimens were obtained from the descending thoracic aorta away from the complex structure near the aortic arch. All adipose and loose connective tissues were excised by gentle dissection. The aorta was next cut axially along the posterior surface between the thoracic ostia. Then, 40ϫ40 mm sections of tissue were marked from the center of the vessel and numbered for future reference. Typically, two to three specimens were obtained from a given vessel, depending on the size of the vessel and location of the distal cut. The adventitial layer was removed and the specimens brought to an approximately uniform thickness of about 2.3 mm using an adjustable height microtome. After microtoming, specimens were washed thoroughly with EGTA solution to remove any Ca ϩϩ released during slicing and stored in fresh EGTA solution until being sutured to the four load carriages as mentioned above. Specimens were trimmed to a final size of 35 ϫ35 mm before suturing.
Six thermal diffusivity measurements were made at room temperature (T ϱ Х16°C). Figure 1 shows a typical T s history in terms of scaled temperature ϭ(T s ϪT ϱ )/(T max ϪT ϱ ) and time ϭt/t 1/2 , where t is the elapsed time after the flash. For a typical value of ␣ 3 ϭ0.13 mm 2 /s and a typical specimen thickness of 2.3 mm, t 1/2 ϭ5.6 s. The duration of the flash is less than 1 ms, which is short enough to be considered instantaneous ͓17͔. The sampling frequency of the thermocouples is 25 Hz and clearly resolves the temperature history ͑Fig. 1͒. In addition to using Eq. ͑1͒, ␣ 3 is calculated using a Marquardt algorithm coupled to a finite difference solution of the diffusion equation ͓15͔. The line in Fig. 1 shows the finite difference solution using the value of ␣ 3 determined from the Marquardt algorithm for a representative specimen. After each flash and data collection, eight minutes elapsed until the next measurement to allow the specimen to regain thermal equilibrium. Following six flashes at this reference state, the specimen was removed from the load frame and its thickness measured in its central region using a micrometer. Electrical continuity between the micrometer base and head ensured that the specimen thickness was measured just as the tip of the micrometer made contact. Once the specimen thickness was determined, the data from each test were analyzed according to ASTM E-1461-92 ͓17͔ to ensure that the coating adequately absorbed the flash energy and there were no substantial parasitic heat losses ͑i.e., to check the applicability of Eq. ͑1͒ for data reduction͒.
Next, the specimen was transferred to a separate heated recirculating bath of three liters of fresh EGTA solution at 75°C. Care was taken to ensure that the specimen was free of mechanical constraints. Measurements with specimens of bovine aorta, during which the specimen remained in the load frame during heating, demonstrated that when constrained from shrinking in the in-plane directions, the in-plane forces reached an asymptote within 1 hour, for Tϭ75°C ͓18͔. Thus, heating for two hours at 75°C in a mechanically unconstrained state was assumed to produce the substantial part of any change in ␣ 3 , should such change occur. Following completion of the heating cycle, the specimen was removed from the chamber, submerged in 1 liter of fresh room temperature EGTA, and allowed to reach thermal equilibrium. The specimen was then returned to the load frame, and the flash protocol repeated.
Results
The radial ͑out-of-plane͒ thermal diffusivity of six specimens from six animals was measured using the flash device and protocol described above. For three specimens, one thermocouple per specimen was used to measure the bottom surface temperature history, while for the others, three thermocouples were used. ͑In principle, only a single temperature sensor is needed for the onedimensional flash.͒ If multiple thermocouples were available, the temperature histories were reduced separately, and after removing outliers as determined by a maximum normal residual test ͓19͔, the results were averaged for each specimen as listed in Table I Uncertainties in the thickness of the specimen may account for scatter in the values of ␣ 3 . Variations in the height of the medial surface of the order of 150 m were measured; smaller variations were observed at the intimal surface. The specimen thickness can also change with the hydration of the tissue and thus, a consistent test protocol was used to minimize variations in the tissue hydration. An uncertainty analysis ͓20͔ based on Eq. ͑1͒ indicated that an uncertainty in the thickness of 150 m yields an uncertainty of 13.5 percent in ␣ 3 , which is approximately equal to the scatter of the measured values.
Discussion
The measurements indicate a 10.1 percent increase in ␣ 3 of bovine aorta due to heat-induced damage. This result seems to differ from that of Valvano and Chitsabesan ͓13͔, who reported that the directionally averaged thermal diffusivity ␣ depended only on the temperature level and was independent of the order in which these temperature levels were considered. This suggests that ␣ is independent of heat-induced damage. Two possible explanations are that: ͑1͒ The samples used by Valvano and Chitsabesan were mechanically constrained during heating, or ͑2͒ the directional averaging of the thermal diffusivity measurements masked the increase in the out-of-plane component. The thermistor probe used by Valvano and Chitsabesan ͓13͔ was pinned to the sample before being placed in the heated bath. While the number of pins used is not mentioned, the number needed to maintain good contact between the probe and the specimen may have imposed a mechanical constriction during heating. Initial flash measurements for which the bovine aortic specimen was mechanically constrained in the in-plane directions demonstrated no significant change in ␣ 3 ͓21͔. This is perhaps consistent with the known effect of mechanical load in delaying thermal damage ͓22͔. In another study, Valvano et al. ͓23͔ demonstrated that the thermal conductivity of bovine aorta is directionally dependent, which suggests the possibility that the components of diffusivity may change differently when damaged by heating. Self-heated thermistors measure the directionally averaged thermal diffusivity such that an increase in the component of thermal diffusivity in one direction may be masked by a possible decrease in another direction.
The increase due to heat-induced damage in ␣ 3 reported here may cause only small increases in the temperature field in clinically relevant situations. For example, 60 s after a hypothetical 2-mm-dia isothermal sphere has experienced a step change in temperature, a 10 percent increase in the thermal diffusivity of the surrounding tissue would lead to increased temperature excesses of only 0.5, 2, and 8 percent at 0.5, 1.5, and 4 mm from the sphere. Nonetheless, there remains a need to study possible changes in the in-plane components of thermal diffusivity and indeed the structural mechanisms by which heat is conducted in soft tissues. Such improved understanding of thermal properties may aid in better clinical evaluation of heat-induced damage such as in burns and thermal therapies.
the Radial Component of Thermal Diffusivity of Bovine Aorta, '' Proc. 1999 Bioengineering Conference, V. K. Goel et al., eds., pp. 607-608. ͓22͔ Chen, S., Wright, N. T., and Humphrey, J. D., 1998, ''Heat-Induced There are roughly 275,000 skeletal defects a year that require bone graft procedures to achieve union ͓1͔. These may include the removal of primary and metastatic tumors, bone loss after skeletal trauma, primary and revision total joint arthroplasty with bone deficiency, spinal arthrodesis, and trabecular voids following osteoporotic insufficiency fractures. Different methods to treat each type of defect have been developed. Most of these procedures employ the use of autograft, where bone is harvested from the patient's iliac crest and then transplanted to the graft site. Unfortunately this procedure may result in significant donor site pain and has the added drawback of a limited supply of graft material. The only other viable option now is allograft, which is available in ample supply, but can be rejected by the host and often needs autograft tissue to initiate osteogenesis. Furthermore, neither autograft nor allograft trabecular bone contributes to post operative skeletal stabilization, and fixation following a bone graft procedure is entirely dependent on instrumentation, immobilization, or both.
The treatment of skeletal defects through the use of bone regeneration scaffolds is a concept that has recently received significant interest within the field of tissue engineering ͓2,3͔. The ability to use this type of a biomaterial in order to facilitate fracture union or spinal arthrodesis could aid a significant number of patients. Surgical time would be reduced with off the shelf availability and a polymeric bone regeneration scaffold could be designed to provide mechanical stability as well as facilitate bone regeneration.
Our lab has developed a novel biodegradable polymer, poly ͑propylene fumarate͒ ͑PPF͒ ͓4͔ for use in a composite bone regeneration scaffold. Variation in composite porosity has been shown to have an effect on the osteoconductive properties of a scaffold ͓5͔, and can be utilized for variable delivery of proteins, other macromolecules, or cells. The scaffold porosity is chosen such that the scaffold is a completely interconnected porous structure after the porogen has leached out. This porous network provides a favorable environment for osteoblast attachment and migration, and the use of increasing amounts of porogen in composite fabrication could have a favorable effect on the short-term mechanical stability of the scaffold. Furthermore, the use of ␤-TCP has been shown to have favorable effects on the strength of PPF composites ͓3͔.
This work explores the mechanical properties of a novel, biodegradable, bone regeneration scaffold and how changes in the relative amount of porogen and ␤-TCP used in scaffold fabrication affect the strength of the material.
Materials and Methods
Scaffold Fabrication. A composite material composed of PPF, tricalcium phosphate, and a leachable porogen NaCl was fashioned into a right circular cylinder 14 cm long and 0.5 cm in diameter using a glass tube injection mold. In this formulation, N-vinyl pyrrolidinone ͑NVP͒ was used as the cross-linking reagent. In a two variable, two level, fractional factorial design, with high and low levels of porogen ͑NaCl͒ and beta-tricalcium phosphate (␤-TCP͒, four different composite groups were prepared ͑Table 1͒.
Each composite specimen was made by combining PPF/NVP at room temperature with differing amounts of NaCl, particle size of 300-425 m, and ␤-TCP. Benzoyl Peroxide ͑BP͒ and dimethyl-toluidine ͑DMT͒ were used as initiator and accelerator, respectively. In a typical reaction, 1 g PPF was mixed with 0.3 mL NVP. Also, 3 mg BP was dissolved in 0.1 mL NVP and the solution was added to the PPF/NVP mixture. Then, 0.5 g ␤-TCP and 0.5 g NaCl was added and the mixture was stirred for 2 minutes, followed by the addition of 1.5 L DMT under rapid stirring for 10 seconds. The well-mixed paste was pressed into a glass tube ͑14 cmϫ0.5 cm͒ using a syringe. After polymerization for 15 minutes, the specimens were removed from the glass tube. Each piece was stored in a desiccator at 4°C. Four specimens were made for each experimental group. For bending testing, 0.5-cm dia rods were fabricated. For compression testing, the rods were cut to 1.3 cm length by 0.5 cm diameter cylinders.
Mechanical Testing. Bending testing of the PPF rods was performed using a servohydraulic materials-testing machine ͑MTS, Minneapolis, MN, USA͒. A four-point loading configuration was used according to ASTM D790-97. The contact points were set with a major span of 6.8 cm and a minor span of 2.3 cm. The length-to-width ratio for the specimens was 13.6:1. A transverse deflection was applied at a rate of 0.5 mm/min until specimen failure. During four-point bending, a constant bending moment is applied over the minor span and increases proportionally with the applied loading. In our testing configuration, the applied moment at the midspan of the specimen, in N-mm, was 11.25 times the force in Newtons. Load and displacement were recorded using a digital computer.
A regression line was fit to the linear portion of the loaddisplacement curve to calculate the modulus of elasticity (E b ):
where: E b ϭ bending modulus of elasticity, MPa aϭdistance from outer support to loading point, mm bϭminor span, mm P/␦ϭslope of the load displacement curve, N/mm Iϭarea moment of inertia, mm 4
In addition, the bending strength at the specimen midspan was calculated from the peak moment applied during bending:
where: Sϭbending strength, MPa Pϭmaximum load, N dϭrod diameter, mm aϭdistance from outer support to loading point, mm Iϭarea moment of inertia, mm 4 Compression testing of specimens was performed using the servohydraulic materials-testing machine. Cylindrical PPF specimens were fabricated with a length-to-diameter ratio of approximately 2.5:1. The specimens were placed between two solid platens and compressed at a rate of 0.2 mm/s. Load and displacement were recorded using a digital computer.
Stress was defined as the observed force divided by the initial specimen cross-sectional area and compressive strain was calculated from the change in cylinder height divided by the original height. A regression line was fit to the linear portion of the stressstrain curve to determine the compressive modulus of elasticity (E c ). The ultimate strength was obtained from the peak of the stress-strain curve.
All mechanical testing experiments were conducted in quadruplicate, except group 2, which was done in triplicate. One specimen in group 2 was excluded because of a visible defect in the rod. The data are expressed as means with standard deviations. A two-factor analysis of variance ͑ANOVA͒ was used, with alpha equal to 0.05 and beta equal to 0.02, to assess the statistical significance of the results. Figure 1 shows the force versus displacement curves from the bending testing. The mechanical testing results for the four PPF/ NVP composite groups are summarized in Table 2 . The mean bending strength ranged from 4.4 MPa ͑SD 1.5͒ to 16.9 MPa ͑SD 6.7͒, while the mean compressive strength ranged from 16.7 MPa ͑SD 0.8͒ to 70.9 MPa ͑SD 8.9͒. The moduli of elasticity for both bending and compression were in the range of 354.1 MPa ͑SD 138.5͒ to 1274.7 MPa ͑SD 125.7͒. The incorporation of ␤-TCP caused an enhancement of the mechanical properties of the composites. Increasing porogen ͑NaCl͒ decreased the bending and compressive strength, but did not affect the modulus of elasticity in bending.
Results
The bending strength and compressive strength are shown in Fig. 2 , while the moduli of elasticity in both compression and bending are shown in Fig. 3 . The between group difference in the mechanical properties tested in this study was found to be statistically significant based on a two-factor ANOVA (pϽ0.001). A significant difference in bending and compressive strength as a Table 1 Formulation of four PPFÕNVP polymer composites with ␤-TCP and porogen "NaCl…. The ratio of NVP to PPF was 0.4 gÕ1 g. The BP and DMT contents were 3 mg and 1.5 L, respectively, based on 1 g PPF. The percentage of porogen "NaCl… was based on the total amount of the composite. function of porogen level was found (pϽ0.001), with increasing porogen leading to a decrease in bending and compressive strength. A statistically significant difference in E c and E b as a function of porogen level was not found (pϾ0.14). The statistical analysis showed that ␤-TCP levels had significant effects on bending and compressive strength as well as modulus of elasticity for both bending and compression (pϽ0.001).
Discussion
All specimens were tested in a dry state according to the method used for human compact bone testing ͓6͔. Each composite specimen tested displayed a compressive and bending modulus of elasticity between 354.1 MPa ͑SD 138.5͒ and 1274.7 MPa ͑SD 125.7͒, which is on the order of trabecular bone ͑100-1400 MPa͒ and similar to the compressive moduli of PPF scaffolds previously fabricated in our lab ͓7͔. Increasing the amount of porogen in the composites decreased bending and compressive strength (p Ͻ0.05). The most likely explanation for the reductions in bending and compressive strength arises from the fact that there is a relative decrease in the cross-linking density of PPF/NVP in composites with higher percentages of porogen. It is also likely that PPF does not bond to the NaCl, resulting in weak points at the interface between the PPF and the NaCl. However, increasing the amount of porogen in the composites did not affect the modulus of elasticity significantly. This may be explained by the fact that the modulus of NaCl is 39 GPa. Thus, the comparatively high modulus of NaCl prevented the overall modulus from decreasing even as the cross-linking density decreased. In agreement with previous studies ͓3͔, increasing the weight percentage ␤-TCP from 25 to 50 percent did have a significant positive effect on both strength and modulus.
Conclusions
This work shows that a biodegradable PPF/NVP scaffold can be designed with mechanical properties on the order of magnitude of trabecular bone. Composite formulations with less porogen and higher ␤-TCP contents have higher strengths and moduli of elasticity than those formulations with higher amounts of porogen and lower amounts of ␤-TCP. Future testing will be required to determine the effect of porogen level on bone regeneration in vivo. In addition, we plan to explore the effect of complete leaching of the porogen prior to testing and the strain rate sensitivity during mechanical testing of PPF composites. 
Introduction
The clinical needs for bone regeneration are diverse, and include applications arising from resection of primary and metastatic tumors, bone loss after skeletal trauma, revision ͑and primary͒ total joint arthroplasty with bone deficiency, spinal arthrodesis, and trabecular voids following osteoporotic insufficiency fractures. Each of these clinical situations may present needs for trabecular ͑cancellous͒ bone, cortical ͑compact͒ bone, or a combination of both these bone types. If the defect is small enough, bone can be harvested from the patient's iliac crest and utilized as an autograft to fill the void and promote fusion. Unfortunately, this is often not possible due to the size of the defect, and the patient needs more bone than the iliac crests can provide. Cadaver allograft bone is one option, and is available in abundant supply. This can be problematic, however, due to the fact that rates of healing and graft incorporation are reduced and rates of infection are higher with the use of allograft, as compared to autograft. Even when autograft is used alone, it has potential problems. The iliac crest donor site often feels quite painful, and the autograft harvest usually adds about 45 minutes to the anesthetic and surgical time, with the attendant potential for increased complications, such as infection.
The treatment regimen for this particular clinical scenario could be improved with the availability of a skeletal regeneration biomaterial that could act as both a delivery vehicle for various bioactive proteins and a scaffold to aid in bone growth. This material could be processed into the specific shape needed and would be bioabsorbable, thus replaced by newly vascularized tissue as the bone remodels along lines of local stress. The use of such a material would eliminate the need to operate on the iliac crest for bone harvest and obviate the need for allograft.
Many recent tissue engineering strategies found in the literature have centered on the use of growth factors to stimulate cellular activity in vivo. Platelet-derived growth factor has long been known to promote wound healing through enhancing the formation of granulation tissue ͓1͔ and has been approved by the US Food and Drug Administration for use in diabetic foot ulcers ͓2͔. Work in nerve tissue engineering has shown that locally delivered nerve growth factor aids in the repair of an injured nerve gap through stimulation of axonal growth in rat models ͓3͔.
Bone morphogenetic protein ͑BMP͒, a family of proteins that are members of the transforming growth factor-beta ͑TGF-␤͒ superfamily, has been discovered to have stimulating effects on osteoblast proliferation and matrix production ͓4-7͔. Early studies have shown that through this effect BMP-2 induces bone formation in both skeletal and extraskeletal locations ͓5-9͔. Further studies have been done that resulted in the elucidation of the effective local concentration of BMP-2 for humans and for experimental rodent models ͓10,11͔. Efforts to integrate this into clinical medicine have focused on the use of BMP-2 to stimulate bone growth in fusion procedures. This has been done experimentally by using a collagen sponge reservoir packed into the fusion void, within which aqueous phase BMP was inserted with the intent that the sponge would help to maintain optimal local levels of BMP for bone growth. Concern regarding hematoma formation and resultant rapid physical desorption of BMP-2 led to an effort to find an improved method to achieve temporal and spatial control of local BMP-2 concentrations.
The encapsulation of drugs, proteins, and other bioactive molecules within degradable materials has long been known to be an effective way to control the release profile of the contained substance. More recently, microencapsulation has been found to have similar effects, and has been used for the controlled delivery of various drugs and active proteins ͓12͔. Our laboratory has successfully applied this technique to encapsulate growth factors such as TGF-␤ and basic fibroblast growth factor ͑bFGF͒ ͓12,13͔.
Our lab has been successful in the production of a shapespecific biodegradable scaffold for bone regeneration that was replaced by vascularized tissue in vivo in a sheep rib model ͓14͔.
The addition of bone growth proteins, such as BMP-2, within this shape specific matrix would result in a composite biomaterial that could have a positive impact on the way that we approach skeletal defects, providing an alternative to bone graft in certain cases. The purpose of this work was to investigate the biologic activity of rhBMP-2 in a cell culture model after the protein has undergone a process of entrapment into and release from polymeric microspheres.
Materials and Methods
Cell Cultures. Five polystyrene 12-well cell culture plates ͑Fisher, Pittsburgh, PA͒ were prepared with the hFOB 1.19 line of clonal human fetal osteoblasts ͓15͔, plated at 42,000 cells per well. Two ml of Dulbecco's modified Eagle's medium nutrient mixture F-12 Ham ͑Sigma, St. Louis, MO͒ supplemented with 10 percent fetal bovine serum ͑Gibco, Grand Island, NY͒ was added to each well and the plates were inserted into a humidified incubator maintained at 34°C. In each plate only nine of the wells were used, with three wells of cells specified as the test group, three as the positive control group, and three as the negative control group. The cells were allowed at least twelve hours for reattachment, during which time the following treatments were prepared.
Microsphere Fabrication. Poly͑DL-lactic-co-glycolic acid͒ ͑PLGA; Medisorb, Alkermes, Cincinnati, OH͒, with a 50:50 lactic to glycolic acid ratio and a weight average molecular weight ͑Mw͒ of 46,000, was used to fabricate microspheres using a double emulsion process. In a 15 ml glass test tube, 0.5 g of PLGA was dissolved in 2 ml dichloromethane ͑Sigma͒ under constant agitation on a Vortex Genie 2 ͑Fisher͒. While maintaining the test tube on constant vortex at approximately 800 rpm, 750 l of aqueous BMP-2 ͑1 mg/ml͒ ͑kindly donated by Genetics Institute, MA͒ was inserted into the test tube mixture and allowed to swirl for 20 seconds. This caused the formation of an emulsion in which a discontinuous phase of the aqueous BMP-2 solution was dispersed in a continuous organic phase, made up of the PLGA dissolved in dichloromethane. Immediately following the preparation of this emulsion, 2 ml of 1 percent poly͑vinyl alcohol͒ ͑PVA, 88 percent mole hydrolyzed, Mwϭ13,000-23,000; Sigma͒ was added to serve as a surfactant, and the mixture was swirled another 20 seconds. The contents of the test tube were then removed from the vortexer and poured into a 250 ml glass beaker containing 100 ml 0.2 percent PVA maintained on a propeller/shaft stirrer ͑Fisher͒ rotating at 250 rpm, and stirred for one minute, at which time the microspheres form. Next, 100 ml of an aqueous solution containing 2 percent isopropanol ͑Fisher͒ was added to the PVA/ microsphere mixture. This mixture was stirred for two hours in a chemical hood, during which time the organic phase solvent, dichloromethane, partitioned into the PVA/isopropanol solution and evaporated, leaving the formed microspheres in the external alcoholic phase. Following this time period, the stirrer was removed and the microspheres were given time to settle to the bottom of the PVA/isopropanol supernatant, which was suctioned off with the use of a vacuum funnel trap. The microspheres left in the bottom of the beaker were washed with distilled, deionized ͑ddI͒ water three times, each time the rinsing solution being suctioned off, and vacuum filtered out of solution using a Whatman 0.45 m cellulose filter ͑Fisher͒ and a polypropylene Buchner funnel ͑Fisher͒. The microsphere formulation process was repeated using 750 l physiological saline ͑without BMP-2͒ as the original discontinuous aqueous phase to form microspheres that would serve as the negative control group in the study.
Release of BMP-2 From Microspheres. A 1.5 ml siliconized polypropylene microcentrifuge tube ͑Fisher͒ was prepared with 0.4 g of microspheres ͑dry weight͒ containing rhBMP-2, to which was added 1 ml of a physiologic buffer comprised of 5 percent human serum in phosphate-buffered saline ͑PBS; Gibco͒. A second microcentrifuge tube was prepared in the same way, this time containing microspheres loaded only with saline. A third microcentrifuge tube was prepared with 0.32 mg rhBMP-2 in 1 ml of the physiologic buffer. These tubes were placed horizontally on the arm of a two-dimensional rocker ͑Fisher͒, set for motions through an arc of Ϫ30/30 deg at 15 cycles per second, and then placed in an incubator maintained at 37°C.
Cell Culture Treatment With rhBMP-2. Following reattachment of seeded cells, the five cell culture plates were removed from the incubator for treatment. The three microcentrifuge tubes were removed from the rocker and allowed two minutes for the microspheres to coalesce at the most dependent portion of the tube. Ten l aliquots of supernatant from the tube containing microspheres loaded with rhBMP-2 were placed in the test group wells. Ten l aliquots from the tubes containing saline-filled microspheres and aqueous rhBMP-2 in buffer were added to the negative and positive control groups, respectively. Following this, the microcentrifuge tubes were returned to the rocker and the cell culture plates were returned to the incubator. The cells were treated in identical fashion at 24-h intervals for five days in an effort to simulate the effects of sustained protein delivery from the microspheres.
Alkaline Phosphatase Assay. One of the five cell culture plates was removed from the incubator for testing at 18, 48, 72, 96 , and 120 h following the first treatment and immediately prior to the treatment scheduled for the same hour. The osteoblasts in the test, positive, and negative control groups of each plate were analyzed for total alkaline phosphatase ͑ALP͒, using a p-nitrophenol conversion kit ͑Sigma͒, and total protein levels, using a bicinchoninic acid protein assay kit ͑Pierce, Rockford, IL͒.
Statistical Analysis. The data were first analyzed using a two-way ANOVA model with repeated measures on one factor, time. Due to a significant interaction found between group and time, further analysis was required. This consisted of creating five separate one-way ANOVA models, with one for each level of time ͑18, 48, 72, 96, and 120 h͒. Each model thus compared the three groups separately for each time period. When the group factor was found to be significant, post hoc comparisons were performed using the Student-Newman-Keuls multiple comparison procedure. The threshold of significance for all statistical tests was set at ␣ϭ0.05. All analyses were conducted using SAS version 6.12 and S-Plus version 3.4 on a Sun Ultra II computer.
Results and Discussion
Biodegradable PLGA microspheres loaded with rhBMP-2 were fabricated using an established double-emulsion-solventextraction technique previously described ͓12͔. Recent work of Peter et al. ͓13͔ showed that using this process, TGF-␤1 was successfully incorporated into the PLGA microspheres and distributed uniformly throughout the polymer matrix. The release kinetics of TGF-␤1 from microspheres in simulated body fluids was fully characterized. Since BMP-2 is a member of the TGF-␤ super family, it is reasonable to postulate BMP-2 used in the present study would have incorporation yields and release kinetics similar to those of TGF-␤1.
Serial treatment of osteoblast cultures with rhBMP-2 released from microspheres resulted in mean alkaline phosphatase/total protein production of 0.43 mol/g/ml at 120 h following the first treatment. Mean alkaline phosphatase/total protein production in the positive and negative control groups were 0.34 and 0.66 mol/ ng/ml, respectively, at the same time point. The mean alkaline phosphatase/total protein levels in the three experimental groups were found to be significantly different at 48, 72, 96, and 120 h. Specifically, the mean alkaline phosphatase/total protein in the negative control group was found to be significantly higher than that of the positive control group and the test group. However, no difference in alkaline phosphatase/total protein level between the 290 Õ Vol. 122, JUNE 2000
Transactions of the ASME groups was observed at 18 hours. A summary of alkaline phosphatase/total protein in the test, positive control, and negative control groups at five time points along the study is presented in Table 1 and graphically in Fig. 1 . As shown in Fig. 1 , the response to rhBMP-2 in both the positive control and test groups had either a time-dependent function or a cumulative dose response based on the dramatic reduction in alkaline phosphatase production beginning at 48 hours. Interesting to note is the fact that although the positive control group was receiving treatments with a constant concentration of rhBMP-2 and the test group was receiving treatments with a presumably increasing protein concentration, cellular expression of alkaline phosphatase was statistically similar in the positive control and test groups. This may indicate that the aliquots for both the positive control and test treatment groups delivered quantities of rhBMP-2 above a minimum threshold level for inhibition of alkaline phosphatase in the cultured cells.
The response of the osteoblasts to the rhBMP-2 released from PLGA microspheres compared to native rhBMP-2 indicates that the protein remains active after the encapsulation process and release from the microspheres. Several prior studies have demonstrated that BMP has stimulatory effects on osteoblast differentiation and an inversely proportional inhibition of osteoblast proliferation ͓16,17͔. With that in mind, the inhibitory effect of rhBMP-2 on hFOB-17 alkaline phosphatase production is counterintuitive, but similar results have been found on lines of osteoblasts treated with other proteins in the TGF-␤ family under specific conditions. TGF-␤ was shown to have a stimulatory effect on differentiation of primary rat calvarial osteoblasts when grown at confluence and an inhibitory effect when the same cells were grown at a lower cell density ͓18,19͔. The cells used in the present study also exhibited a decreased alkaline phosphatase activity upon the addition of BMP-2. Further studies are underway in our laboratory to test the effects of BMP-2 released from PLGA microspheres on the murine W-20 cell line, which demonstrates increased alkaline phosphatase production under the influence of rhBMP-2 ͓20͔.
Puleo et al. ͓21͔ recently reported release of rhBMP-2 from bioerodible porous PLGA microspheres, but several key factors make this work different. Instead of soaking preformed, porous PLGA microparticles in aqueous rhBMP-2 to facilitate protein entrapment and physical adsorption, in this work the rhBMP-2 entrapment is coincident with nonporous microsphere formulation. Thus the protein is distributed uniformly inside the microspheres, and full release is dependent on both protein diffusion and polymer degradation ͓13͔.
The fact that rhBMP-2 remains active after encapsulation within, and release from, PLGA microspheres clarifies an important step in tissue engineering strategies aimed at the use of sustained levels of rhBMP-2 to stimulate bone regeneration and remodeling. Incorporation of this controlled release technology into the biodegradable scaffold already produced by our lab ͓14͔ would result in a skeletal regeneration biocomposite material that could act as both a delivery vehicle for rhBMP2, and a scaffold to provide mechanical strength and an osteoconductive matrix. This material can be processed into the specific shape required for a particular skeletal regeneration site. The successful fabrication of this and similar bone regeneration scaffold materials would decrease the need for bone harvesting procedures or the use of bone allograft and thus provide a promising alternative for bone regeneration.
Conclusions
Recombinant human BMP-2 was encapsulated into synthetic biodegradable PLGA microspheres and released in simulated body fluids at physiological temperature. BMP-2 was shown to remain active following encapsulation process and in vitro release. Released BMP-2 inhibited the differentiation of cultured osteoblasts, as indicated by decreased alkaline phosphatase activity over a period of 5 days. Table 1   Table 1 Mean alkaline phosphataseÕtotal protein "molÕngÕml… in human fetal osteoblast cell cultures treated with rhBMP-2 released from PLGA microspheres "test sample…, rhBMP-2 solution "positive control…, or release medium from microspheres loaded with ddI water "negative control… 
